The Professional Diploma
This course is the third part of the three-part Professional Diploma of Skin Cancer Medicine. The education pathway is Professional Certificate of Skin Cancer Medicine, Advanced Certificate of Skin Cancer Medicine and Professional Diploma of Skin Cancer Medicine.
Entry Requirements and course requisites
This course is for general practitioners only. Participants must have completed the Advanced Certificate of Skin Cancer Medicine (or a qualification deemed equivalent).
Recognition of Prior Learning
Professionally accredited qualifications and prior studies may be recognised for entry into this course. Please send an email to firstname.lastname@example.org for an individual assessment of your prior qualifications and experience. This email should contain information about your educational history and work experience that specifically pertain to the content and procedures covered in the Professional Certificate
Doctors who have completed The University of Queensland certificate courses in skin cancer medicine and therapeutics will gain credit into the professional diploma program, providing the relevant HealthCert assessment has been completed.
Doctors who have completed the Certificate in Primary Care Dermatology with the RACGP (modules 1-5) may complete the relevant HealthCert assessment for the Advanced Certificate in Skin Cancer Medicine and then progress to the Professional Diploma of Skin Cancer Medicine (please ask a HealthCert Education Advisor for the process).
Other professionally recognised qualifications and prior studies may be recognised for entry into this course. Please ask a HealthCert Education Advisor for an individual assessment of your prior qualifications and experience.
Course Contents and LEARNING OUTCOMES
This course will focus on lesion and field directed treatments as well as skin imaging, drug therapy, special situations, treatment of rare/aggressive skin cancers and studies of both melanoma and non-melanoma treatments.
The theory sessions cover:
- Merkel Cell and rare/aggressive skin cancers
- Cutaneous cryosurgery and
- Managing special cases and complications, including
- Lesion- and field-directed treatments
- Advanced histopathology
- Dermal imaging
- Factors influencing the choice of treatment
Course participants will:
- Participate in discussion boards and evaluate skin cancer cases
- Receive a comprehensive course folder and research/readings in the field
- Access video presentations from experts in the field with the opportunity to replay
- Participate in webinars with experts and professional colleagues
- Receive ongoing support post-course through webinars and case review
Module 1: Topical treatments and lesion-directed treatments
Module 2: Field treatments including PDT, Diclofenac, IngenolMebutate, 5-FU and Imiquimod
Module 3: Management of special cases including immunosuppressed patients
Module 4: Chemoprevention in skin cancer medicine
Module 5: Factors influencing the choice of treatment
Module 6: Cryo and electrosurgery
Module 7: Merkel Cell carcinoma and rare/aggressive melanoma and non-melanoma skin cancers
Module 8: Skin imaging techniques for melanoma and non-melanoma skin cancer
Expert conclusion: Treatment of metastatic melanoma including recent advances in melanoma treatment
Examination preparation: This exam preparation webinar will summarise the course content and provide the opportunity for course participants to submit questions that will be answered during the webinar. The focus will be on preparing for the final examinations.
Patient cases with problem solving analysis and decision making will be included throughout.
Meet Your Instructors
Prof Harald Kittler
Professor of Dermatology at Medical University of Vienna, Austria
Prof Richard Usatine
Professor of Dermatology and Cutaneous Surgery at the University of Texas, USA
Dr Simon Clark
Histopathologist & Senior Lecturer, The University of Queensland
Dr Iris Zalaudek
Research Director of the Non-Melanoma Skin Cancer Unit, Medical University of Graz, Austria
Dr Aimilios Lallas
MD PhD MSc
Dermatologist-Venereologist, Aristotle University, Greece
Dr Luc Thomas
Professor and Chairman Department of Dermatology, Medical University of Lyon, France
Dr Elvira Moscaarella
Dermatologist, S.Maria Nuova Hospital, Reggio Emilia, Italy
A/Prof John Pyne
MBBS PhD FSCCA
Associate Professor of Skin Cancer Medicine at the University of New South Wales
Dr Philipp Tschandl
Dermatology Resident at Medical University of Vienna, Austria
Dr Zoe Apalla
Consultant Dermatologist at State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece
Dr Teresa Troiani
Second University of Naples, Italy
Trimester 3 | 2017
Application deadline: 1 Sep 2017
Course starts: 4 Sep 2017
Exams open: 14 Dec 2017
Course ends: 29 Dec 2017
Trimester 1 | 2018
Application Deadline: 5 Jan 2018
Course Starts: 8 Jan 2018
Exams Open: 2 Apr 2018
Course Ends: 27 Apr 2018
Trimester 2 | 2018
Application Deadline: 4 May 2018
Course Starts: 7 May 2018
Exams Open: 30 Jul 2018
Course Ends: 24 Aug 2018
|REGULAR TUITION FEE
||EARLY BIRD RATE||DEFERRED PAYMENT|
Professional Certificate Only*
Professional Certificate Only
Professional Certificate Only
$845 x 4
$860 x 7
$865 x 9
Different payments options available.
|Register 30 days prior to the course commencement date.||Defer your payments over several months.|
*If you choose the online version of the Professional Certificate of Skin Cancer Medicine course, further price reductions will apply.
GP REGISTRARS: Doctors in training who are on a recognised pathway to General Practice Registration through a recognised Australian training provider receive a HealthCert Scholarship.
Course Delivery and Assessment
This final stage of the Professional Diploma
In order to meet the requirements of professional and academic learning, the course assessment includes professional requirements and two online examinations.
- Develop a report/explanation of how the learning from this course will help you with your professional development.
- Complete a literature review of three articles nominated by the course chair.
- Document with photographs 25 related cases including application of the knowledge
- There is a knowledge-based examination and an application-based examination which are both equally weighted. It is therefore not possible to pass this course on knowledge alone; knowledge must be successfully applied to patient cases in order to pass the course. The pass mark for online examinations is 80 percent.
HealthCert recommends completion of all requirements at your convenience within six to nine months of the completion of the course.
CERTIFICATION AND ACCREDITATION
RACGP: 40 Category 1 QI&CPD points
ACRRM: 30 PRPD points
This certificate course:
- Is recognised by Royal New Zealand College of General Practitioners (RNZCGP).
- Is accredited by the Skin Cancer Institute (SCI) and may be used as part of an application for Certified Skin Cancer Doctor credentials.
- Has been collaboratively designed with, and is annually reviewed by, Professor David Wilkinson, Deputy Vice Chancellor at Macquarie University.
- Considered for APEL/RPL by a University of Manchester in the UK towards a Master degree.
- Qualifies for a Clinical Attachment in France at the University of Lyon.
- Qualifies for a Clinical Attachment in Austria at the University of Vienna.
Membership of the Skin Cancer Institute is recommended and doctors may apply for Certified Skin Cancer Doctor credentials.
Publications Pathway: For HealthCert Professional Diploma Alumni
HealthCert Professional Diploma Alumni may submit their own cases for publication in the HealthCert Case Compendium that is published annually. All cases will be reviewed by HealthCert experts before publication. These compendium cases will also be published electronically on the HealthCert Blog. Submissions are welcome every year for publication. All selected authors names will be printed in the compendium and doctors may wish to purchase a copy of the HealthCert Case Compendium for their waiting room.
Certified Clinical Attachments Pathway
Clinical Attachments are optional and available on a 1:1 or small group basis. These provide the opportunity to observe skin cancer medicine treatments and ask questions of the expert performing the treatments. In addition to clinical attachments in Australia, university teaching hospitals at the University of Lyon and the University of Vienna are available for clinical attachments. HealthCert certificates and university statements are awarded for participating in clinical attachments.
The Medical University of Vienna is the largest medical organisation in Austria, as well as one of the top-level research institutions in Europe and provides Europe's largest hospital, the Vienna General Hospital, with all of its medical staff. The Vienna General Hospital has about 100,000 patients treated as inpatients and 605,000 treated as outpatients each year.
The dominant areas of study covered by The Université Claude Bernard Lyon 1 are science and medicine. Attached to the university are the "Hospices civils de Lyon" including the "Centre Hospitalier Lyon Sud", which is the largest teaching hospital in the Rhône-Alpes region and second largest in France. Out of the 2630 faculty 700 are also medical practitioners at local teaching hospitals.
International Postgraduate Pathway: Master of Skin Ageing and Aesthetic Medicine
Doctors who successfully complete any of the HealthCert courses in Skin Cancer Medicine and Aesthetics Medicine will be eligible to apply for Accreditation of Prior Experiential Learning (APEL is the same as RPL) for the unit “Fundamentals of Skin Ageing” (MEDN67501) which is part of the Masters of Skin Ageing and Aesthetic Medicine at the University of Manchester.
View the University of Manchester program here.
Please ask a HealthCert Education Advisor for the HealthCert Electronic Portfolio Form and follow the steps outlined on this form.
If your application is successful, you will only need to complete one practical assessment for the unit during a short practicum in the UK and no fees will apply for the unit " Fundamentals of Skin Ageing" (MEDN67501).
Please note that APEL is not automatic. This is a highly competitive "Gold Standard" program with only 20 places available each year. Each applicant is assessed individually, depending on the background qualifications and experience of the person applying to ensure the standards are kept very high. Doctors who complete the HealthCert courses have a better chance of being one of the 20 accepted because the Manchester University Academic Committee has reviewed and recognised the HealthCert course content.
|Dual Award with||Postgraduate RPL with||Clinical Attachment with|
|Clinical Attachment with||Clinical Attachment with||Accredited by|
|Accredited by||Accredited by||Accredited by|